At least four Chinese humanoid robotics companies have withdrawn or indefinitely postponed initial public offering applications after regulators challenged whether their financial performance reflects actual market traction or simply government-backed pilot programs, according to three people with direct knowledge of the review process. The China Securities Regulatory Commission has flagged concerns that valuations exceeding $1 billion in some cases rest on revenue streams tied almost entirely to state-funded research initiatives and municipal technology demonstration projects rather than recurring commercial contracts.
The regulatory intervention arrives as Chinese humanoid robotics firms collectively raised more than $2 billion in venture and strategic funding between January 2025 and mid-2026, with at least nine companies achieving unicorn status during that period. Shenzhen-based companies including Galbot, Agibot, and Fourier Intelligence had filed preliminary IPO documents with exchanges in Shanghai and Shenzhen between March and July 2026. Now those filings face extended scrutiny or have been pulled entirely. One person familiar with the CSRC's position said regulators are demanding that applicants demonstrate at least 40 percent of revenue originates from repeat customers operating without direct government subsidies, a threshold most humanoid robotics companies cannot currently meet. The concern centers on distinguishing between genuine product-market fit and what amounts to publicly funded research and development dressed up as commercial deployment.
The pattern regulators identified involves companies reporting tens of millions in annual revenue from selling humanoid platforms priced between $30,000 and $90,000 per unit to municipal governments, state-owned manufacturers, and universities participating in national artificial intelligence initiatives. While those transactions generate legitimate cash flow, the CSRC questions whether demand persists once subsidies expire or quotas are filled. One humanoid robotics executive, speaking on condition of anonymity because IPO discussions remain confidential, said regulators specifically asked his firm to explain why reported orders from three provincial governments accounted for 78 percent of 2025 revenue but had not yet converted into follow-on purchases for 2026 or 2027. The executive said his company was instructed to either secure binding multi-year contracts from non-governmental customers or withdraw its listing application. Another person close to the review process said the CSRC is particularly focused on whether companies have business models beyond hardware sales, such as software licensing, fleet management services, or application-specific tooling that would indicate deeper customer relationships.
China's humanoid robotics sector has developed with explicit state support since late 2023, when the Ministry of Industry and Information Technology designated humanoid robots as a strategic priority and set a target of mass production capability by 2025, later revised to 2027. That policy framework triggered a wave of municipal incentives, with cities including Shanghai, Shenzhen, Beijing, and Hangzhou offering grants and subsidies for companies developing humanoid platforms and local manufacturers deploying them in pilot programs. The result has been rapid technical progress and an explosion of startups, but also a disconnect between impressive unit shipment figures and evidence of sustainable demand. Shanghai-based Fourier Intelligence, for example, reported shipping more than 400 humanoid robots in 2025, but the company's public statements indicate the majority went to research institutions and factories participating in government-backed automation trials. Beijing-based Galbot disclosed delivering 320 units in the same period, with approximately 60 percent deployed in state-owned logistics and manufacturing facilities under programs subsidized by provincial governments.
What to Watch: Monitor whether affected companies revise business models to emphasize software and services rather than hardware sales, potentially bundling robots with multi-year support contracts to satisfy CSRC revenue diversity requirements. Track announcements from Shenzhen and Shanghai stock exchanges regarding any humanoid robotics IPOs that do proceed, as approval criteria will set precedent for the sector. Watch for shifts in venture funding, as the IPO roadblock may redirect private capital toward companies with demonstrated commercial traction outside government programs. Pay attention to quarterly shipment data from major players like Fourier Intelligence, Agibot, and Galbot through the end of 2026 to see whether non-subsidized sales materialize.
